PFE Stock Price - Pfizer Inc - (PFE)
- Prev. Close: 34.11
- Open: 34.22
- Daily Range: 34.070 - 34.400
PFE NEWS FROM BIDNESS ETC
Driven By Pfizer Inc. And Novartis AG (ADR), Global Breast Cancer Drug Sale...
Global sales of branded breast cancer drugs by Pfizer, Roche, Novartis, and many other drug-makers may soar past $25 billion in 2020, Bloomberg report...
Pfizer Inc. Mega-Merger Talk: The Speculated Targets
Bidness Etc looks at the possible takeover options for Pfizer, as cited by analysts
Pfizer Inc.-GlaxoSmithKline Merger Talk: Deutsche Bank Speculates “Pfizer...
Bidness Etc takes a look at Deutsche Bank’s views on a possible Pfizer-Glaxo mega-merger
- Pfizer Inc. To See Boosting Revenues On New Drugs Growth Through 2020
- Inhaled Insulin: How MannKind Corporation Can Make It Work Better Than Pfiz...
- Early ORR For Pfizer (PFE) And Merck’s (MRK) Avelumab In Lung Is Unimpres...
- Pfizer Inc., Merck KGaA (ADR) To Set Strong Foothold In Cancer Immunotherap...
- Biogen Inc (BIIB) May Soon Trump Pfizer In Global CNS Drug Sales
- Pfizer Inc. (PFE) Attains Stake In AM-Pharma; Locks In Right To Buy Whole C...
- Pfizer Inc. May Soon Become A Successful Turnaround Story
- Driven By Amgen, Inc. (AMGN) And Novartis AG Drugs, Sales For ALL Treatment...
- Pfizer Inc. (PFE) China Sales Boosted As Viagra Gains Demand
More News From Bidness
Pfizer Inc (PFE) Cuts 2015 Guidance, Q1 Earnings Exceed... PUBLISHED: Apr 28, 2015 at 8:41 am ESTSwedish Rare Diseases Drug-Maker Sobi Soars On Takeover... PUBLISHED: Apr 28, 2015 at 7:26 am ESTWhisper Numbers: Pfizer Inc. (PFE), Merck & Co., In... PUBLISHED: Apr 28, 2015 at 5:25 am ESTPfizer Inc. (PFE) Rumored To Be Eyeing British Giant Gl... PUBLISHED: Apr 27, 2015 at 6:17 am EST
Pfizer Inc. (PFE) Q1FY15 Earnings Preview: What You Need To Know PUBLISHED: Apr 23, 2015 at 5:35 am EST
Pfizer Inc. (PFE) Stock Update: Healthy Cancer Drug Pipeline Promises Strong Revenue Growth PUBLISHED: Apr 23, 2015 at 5:35 am EST
Pfizer has been performing well of late with its collaboration agreements for oncology drug development and the success of its vaccine business. The stock has closely echoed the movement of the NYSE ARCA Pharmaceutical IndexREAD MORE
Pfizer Inc. (PFE) Wins FDA Breakthrough Therapy Designation For Lung Cancer Drug Xalkori PUBLISHED: Apr 22, 2015 at 6:58 am EST
The designation comes on the back of positive results from an extended Phase I study on the drugREAD MORE
Pfizer Inc. (PFE) And Provectus Biopharmaceuticals Get US Patent For Cancer Drug PUBLISHED: Apr 20, 2015 at 10:36 am EST
Pfizer and Provectus were awarded US patent protection today for their experimental cancer treatment PV-10READ MORE
Pfizer Inc. (PFE) Victorious In First Trial Over Zoloft Birth-Defect Claims PUBLISHED: Apr 20, 2015 at 6:16 am EST
Pfizer scored big past Friday as St. Louis court rejected claims that Zoloft caused birth defects in children born to mothers who took the drug during pregnancyREAD MORE
Mylan NV (MYL), Pfizer Inc. Reach Settlement For Viagra Patent Litigation PUBLISHED: Apr 14, 2015 at 9:15 am EST
As part of the settlement, Pfizer has granted Mylan the right to launch its biosimilar, Sildenafil Citrate, inside the US by as soon as December 2017READ MORE
Pfizer Inc. Accused Of Withholding Information On Risks Associated With Antidepressant Zoloft PUBLISHED: Apr 10, 2015 at 7:17 am EST
Pfizer is accused of knowing that the antidepressant posed risk of birth-related heart defects in babies of mothers who took the drugREAD MORE